Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody

Catalog No. ABIN7598002

The Human Monoclonal anti-SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody has been validated for not_set. It is suitable to detect SARS-CoV-2 Spike (Sotrovimab Biosimilar) in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody (ABIN7598002)

Target: SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-SARS-CoV-2 Spike (Sotrovimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Sotrovimab Biosimilar Antibody

Specificity: Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.03 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Target: SARS-CoV-2 Spike (Sotrovimab Biosimilar)

Alternative Name: Sotrovimab Biosimilar

Target Type: Biosimilar

Background: Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2

UniProt: P0DTC2

CAS-No: 2423014-07-5